{"name":"Inder Paul Singh, M.D.","slug":"inder-paul-singh-m-d","ticker":"","exchange":"","domain":"","description":"Inder Paul Singh, M.D. is a specialty pharmaceutical company focused on developing and commercializing innovative ophthalmic therapies. The company's lead product is a combination of Ketorolac, moxifloxacin, and prednisolone acetate, currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPaEdJaUhRZ3U4d3R2MS1NVDNXSmJNazUyVndJa3BvWkp3SHpTWjRXSEQzNGhrMGxsUUVRN19GQl8yMHBENzFmNE1ZUWF1UUsyU2lsYTl3VGEzZHg5cWozVDg5R1NvaXdVblEwVWE2YWV5dWkyNzNsdzhOVXduWmR6OF9JWm5xTTRKVm9HT0Vvc1M3MU5yLThia3luRzZvVzhNRk4tdTFaOA?oc=5","date":"2025-10-26","type":"pipeline","source":"Ophthalmology Times","summary":"Evolving glaucoma therapy: A new era of interventional strategies - Ophthalmology Times","headline":"Evolving glaucoma therapy: A new era of interventional strategies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZFE1ZmZNbG1Eekp6a0h5Wm1nOEF1Ti15Z0UzYnpiOEFFV0lFV0FPZDdIckVLN29nRTB0S3BFdXk0a0UtWTlfX3U1cFdONXJteUZ0WUQzS0F6ck5sSXc0YXRYQ21zbmVsNG5CR2czYkZkbFZBZkFDNTliMmxCWkpIM010ZUR0THFvRVZhcTdEVHN0VjlIWnRFY0ZucV9tRmJ3ZUc3cTBqMkswOWZyemlCU1EwVFBaUjF0X1piaWNWbTN2M0k?oc=5","date":"2025-10-09","type":"pipeline","source":"Ophthalmology Times","summary":"AAO 2025: Technician training platform expands education opportunities in ophthalmology - Ophthalmology Times","headline":"AAO 2025: Technician training platform expands education opportunities in ophthalmology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPdmtSNzRBd0MyWmVSNTF2Y2pGNVZUVU5BMkFoSFA0QVdhTW9CNWx0eG5NYnhhZG5ZSWJ1enRlaW5oaWRZR0VoLURWaWN0dWdWemlFWTd5RGJ4emZjZGNtNU53NmhIdHhZaVNzMFJWUTI3NUxnMy1SdWppWkNLSUVTVElqbjFNTEZkLXJLa3k0djlBX3BWOXdCT1NudmJZb1NzOXVyeA?oc=5","date":"2025-10-08","type":"pipeline","source":"Ophthalmology Times","summary":"Ocular surface: Targeted therapies for a multifactorial problem - Ophthalmology Times","headline":"Ocular surface: Targeted therapies for a multifactorial problem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZ0I0VUJHUFBvZi1mQU4xMHFKdU8xbjVZZmdkekdYazNRM1liWlQtY09JQ0dTWXZiLTFaeHlWNzZWdDloeDE2dU1IVjllUVVIR1QycmtIOFlSemNSSlRrRnF3Uy1QVmMweTRQdFpHSURTMzFkVHdjUENBOVZocFVxVGVkSHhfMXE3Q0ZQdU1oSVpjTkRYQ0UxV3NLUm1yZXBoZVBQZERUQi1FUQ?oc=5","date":"2025-09-12","type":"pipeline","source":"Ophthalmology Times","summary":"Interventional Approaches to Lower IOP and Minimize Medication Use - Ophthalmology Times","headline":"Interventional Approaches to Lower IOP and Minimize Medication Use","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPQkFtQUhDWGF1SGs2ZTJ4VUNtZTJIblV4STN1Z0ROUl9Tck1rV3JuWm1IM3RFYTRVY2xpYUYzdkVQQUNDYzZRV2hXY1MzenoxSlZXM1NHbVA2QlFMVTR5UFJ6LWZodzVscXJwWTI5cnFER2J6MTlZUGZlVll6THd6TGItQjBJSW5wcHQ5WGVWMmdVd1BPMWE2bFlMOWt2cmNrMWVlOXpERzB1aHF3akZWa3F4S2gzMGtS?oc=5","date":"2025-09-12","type":"pipeline","source":"Ophthalmology Times","summary":"Surgical Considerations for Implanting Travoprost Intracameral Implant (iDose) - Ophthalmology Times","headline":"Surgical Considerations for Implanting Travoprost Intracameral Implant (iDose)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQaGRmMDQ0ajhuM3RTcHd5UTRnWjhZVjU2YVlnVFdma2lzWnBtSVYwZGlxYXNmYUpPOUZYX1ZWS014dHRoUVd3S28wdFVwZm5aR0lheWgwRGIyLUl6MjRtQ1lHSjBJbWFMZEpFZERESXFnb3pRN0ZuWFpnX01EZTU5OFRhNVJwQkdHSDN4QUR5RFQwQkVCX0tqTGlpckJiQ19XSUl5cUZLaV9FWjVrejZfSmZPRUxqSmI4dXlteTBGU1FTcllBZDZuTzZIaDViN1pLcGttbWFlSF8zZks4N0VxZQ?oc=5","date":"2025-02-19","type":"pipeline","source":"BioSpace","summary":"Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension - BioSpace","headline":"Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOYWV2SUJiakY5YmlZUUhyX19OXzVjS3Q2Tkg5bEdGTENZcFZ4MWt0YzBOaGszQXBGU3dGeVZIQWg1SHktMzNpU0loTE1CREVzQWhGTnlRWmJROGx1YVNYLWVEUEg5S0VOU2hIYWRuZVNCelFnRnpYMktFM244Sllwdy0tMFZPNnUtWmsydm9XMXdVQzBV?oc=5","date":"2025-02-11","type":"pipeline","source":"EyeWorld","summary":"MIGS expansion and where it fits in interventional glaucoma - EyeWorld","headline":"MIGS expansion and where it fits in interventional glaucoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQWjBvYTNaTGFfbkhXZjV3cm9INEQ2Z1FGZl90UkRCVXZwVENkTURNNGJxamdlc0ZRRGUwa21GbVpXa1pLc1lFMTRMTlJYVHp4R1pqMl9JdTFDeWlwZGotMzkwWW9RWENxZ0NQY2tLZDJQTzdjTUlSTXFCNEZXenpjTHNxR282NEc1QnFRbWt5dEFhZDJhTzJpdkI1NHRKODNqdGR1UHliMFZWM29mdkE?oc=5","date":"2021-05-19","type":"pipeline","source":"Healio","summary":"Intracapsular administration may simplify Dexycu technique - Healio","headline":"Intracapsular administration may simplify Dexycu technique","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFB4MDNWNDNLX21tTWZuMGVDVmxYR0swTnNmNnk5OUwwemVHcktXLXRzM0FrbTFidlRHVVBkd2w4UDRJR240T1VJU2h1X0JDZW40RDN1aDNXdlJPanhwcHFqM3hlX2JYNWFW?oc=5","date":"2021-05-10","type":"pipeline","source":"EyeWorld","summary":"Streamlining glaucoma care - EyeWorld","headline":"Streamlining glaucoma care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNTFB6OEVqQ0hwVjFxNUw0REJKdmdFLUVoRzRWVWE4RGZNOGxIekt3M2JsSVFXTVl5OGNqV0I4YS13MjRtVDVZTG14NlhDakJXVnB6VUkxMU5UMDA5eDlreFhIcHgtbENBa0FzeE44LWkxcFhvdHBKNDk0SFZWMHh4b09pT2VRTkFqcnhFbElRU1RqUGt1czJIM25jZkw5aEUtT3pEQllIdw?oc=5","date":"2020-09-03","type":"pipeline","source":"Healio","summary":"When to use which MIGS approach is a nuanced decision - Healio","headline":"When to use which MIGS approach is a nuanced decision","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNdl8tRlpzZElrdEJCZlBEQkQzdTVQaW05U2pGVnkweC1pQWxZU0ZjQmM3cmI2aVg2OGlaM3VWZjd5czNKV0xXNEVxcFM5YXNGTUNDSzJxZGlUT2NXSGVqT3JYdFFoUDFuZjhxU1R2UElLOEpBTS1ZNENfVFBmNzNqX0NsaDJLQmpJMl9jNWpLU2Jsb0F0TUczZXZUWQ?oc=5","date":"2019-05-21","type":"pipeline","source":"Ophthalmology Times","summary":"MIGS developments continuing to transform glaucoma surgery - Ophthalmology Times","headline":"MIGS developments continuing to transform glaucoma surgery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOMHFZaXlkQ29yUVNNWmprYlhUTnZ4LVJ6ZkROcWRLYjdsbGhON1dMREFMX19BdWhLM2ozbWxINHgwWG1Sc0JWQ1VYdmQ5RnZYT3pmQlJlT0oxRnItQ2dVRU5sXy15SzJqM0wtZDFtRndna0hNMWdBellsYW9iRU9wbF96S3dVdUxrbUFBTXE5YVd2QWVNRDRVZk9Bd0MxMm41VFUwNm5tdw?oc=5","date":"2017-03-28","type":"pipeline","source":"Healio","summary":"Surgeons seek criteria for selecting new MIGS options - Healio","headline":"Surgeons seek criteria for selecting new MIGS options","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}